Craneware plc
("Craneware", "the Group" or the "Company")
Transaction in Own Securities and Total Voting Rights
On 16 July 2014 Craneware bought for cancellation a total of 393,816 ordinary shares of 1 pence each ("Ordinary Shares") representing approximately 1.46 per cent of the voting rights in, and the issued ordinary share capital of, the Company at a price of 527.5 pence per share.
Following the cancellation of these shares there will be 26,614,947 Ordinary Shares in issue with each Ordinary Share carrying the right to one vote. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Craneware plc, under the Disclosure and Transparency Rules.
For further information, please contact:
Craneware plc |
Peel Hunt |
Newgate Threadneedle |
+44 (0)131 550 3100 |
+44 (0)20 7418 8900 |
+44 (0)20 7653 9850 |
Keith Neilson, CEO |
Dan Webster |
Caroline Forde |
Craig Preston, CFO |
Richard Kauffer |
Fiona Conroy |
|
|
Heather Armstrong |
About Craneware
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.
